chr19-35030858-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_001037.5(SCN1B):​c.38T>C​(p.Leu13Pro) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000345 in 870,084 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L13L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000067 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000028 ( 0 hom. )

Consequence

SCN1B
NM_001037.5 missense, splice_region

Scores

5
4
9
Splicing: ADA: 0.0004213
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: -0.0190

Publications

2 publications found
Variant links:
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
HPN-AS1 (HGNC:47041): (HPN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001037.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1B
NM_001037.5
MANE Select
c.38T>Cp.Leu13Pro
missense splice_region
Exon 1 of 6NP_001028.1
SCN1B
NM_199037.5
c.38T>Cp.Leu13Pro
missense splice_region
Exon 1 of 3NP_950238.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1B
ENST00000262631.11
TSL:1 MANE Select
c.38T>Cp.Leu13Pro
missense splice_region
Exon 1 of 6ENSP00000262631.3
SCN1B
ENST00000415950.5
TSL:1
c.38T>Cp.Leu13Pro
missense splice_region
Exon 1 of 3ENSP00000396915.2
SCN1B
ENST00000638536.1
TSL:1
c.38T>Cp.Leu13Pro
missense splice_region
Exon 1 of 5ENSP00000492022.1

Frequencies

GnomAD3 genomes
AF:
0.00000671
AC:
1
AN:
149058
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000149
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000277
AC:
2
AN:
721026
Hom.:
0
Cov.:
10
AF XY:
0.00000290
AC XY:
1
AN XY:
344252
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
13964
American (AMR)
AF:
0.00
AC:
0
AN:
3890
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
7238
East Asian (EAS)
AF:
0.00
AC:
0
AN:
11058
South Asian (SAS)
AF:
0.0000619
AC:
1
AN:
16146
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
13058
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1724
European-Non Finnish (NFE)
AF:
0.00000159
AC:
1
AN:
627394
Other (OTH)
AF:
0.00
AC:
0
AN:
26554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000671
AC:
1
AN:
149058
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
72690
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40914
American (AMR)
AF:
0.00
AC:
0
AN:
15062
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3430
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5044
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.0000149
AC:
1
AN:
66916
Other (OTH)
AF:
0.00
AC:
0
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:3
Apr 16, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 20, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 09, 2020
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SCN1B c.38T>C (p.Leu13Pro) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 7.1e-06 in 140328 control chromosomes (gnomAD v3). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.38T>C in individuals affected with SCN1B-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. Six ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

Brugada syndrome 5 Uncertain:1
Oct 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 13 of the SCN1B protein (p.Leu13Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of SCN1B-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 190870). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Generalized epilepsy with febrile seizures plus, type 1;C2748541:Brugada syndrome 5;C3809311:Atrial fibrillation, familial, 13;C4479236:Developmental and epileptic encephalopathy, 52 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Uncertain:1
Feb 11, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 38174099)

Cardiovascular phenotype Uncertain:1
Nov 17, 2018
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.L13P variant (also known as c.38T>C), located in coding exon 1 of the SCN1B gene, results from a T to C substitution at nucleotide position 38. The leucine at codon 13 is replaced by proline, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Pathogenic
0.40
D
BayesDel_noAF
Pathogenic
0.33
CADD
Pathogenic
26
DANN
Benign
0.96
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.12
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.37
T
M_CAP
Pathogenic
0.99
D
MetaRNN
Uncertain
0.63
D
MetaSVM
Uncertain
0.67
D
MutationAssessor
Benign
0.0
N
PhyloP100
-0.019
PrimateAI
Pathogenic
0.85
D
PROVEAN
Uncertain
-2.4
N
REVEL
Pathogenic
0.77
Sift
Uncertain
0.023
D
Sift4G
Benign
0.073
T
Polyphen
0.84
P
Vest4
0.41
MutPred
0.72
Gain of loop (P = 0.0195)
MVP
0.96
MPC
1.1
ClinPred
0.25
T
GERP RS
3.2
PromoterAI
-0.036
Neutral
Varity_R
0.76
gMVP
0.87
Mutation Taster
=60/40
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00042
dbscSNV1_RF
Benign
0.020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs786205834; hg19: chr19-35521762; API